Literature DB >> 20159492

Predictors of mortality in elderly subjects with obstructive airway disease: the PILE score.

Nitin Mehrotra1, Amado X Freire, Douglas C Bauer, Tamara B Harris, Anne B Newman, Stephen B Kritchevsky, Bernd Meibohm.   

Abstract

PURPOSE: To identify significant covariates in addition to spirometry that predict mortality in elderly subjects with obstructive airway disease (OAD).
METHODS: Two hundred sixty-eight (268) participants with OAD from the Health, Aging and Body Composition study, a community-based observational cohort of well-functioning elderly aged 70-79 years, were followed on average for 6.1 years. Covariates related to pulmonary and physical function, comorbidity, demographics, and three inflammatory markers (interleukin-6, tumor necrosis factor-alpha, C-reactive protein) were evaluated for their association with all-cause mortality (31%) by means of Kaplan Meier analysis and Cox proportional hazards modeling.
RESULTS: Percent predicted forced expiratory volume in one second (PPFEV1; hazard ratio [HR] = 2.03, p < 0.0001), knee extensor strength (HR = 1.36, p = 0.0002), interleukin-6 (HR = 1.37, p = 0.0002) and 400 m corridor walk time (HR = 1.24, p = 0.008) significantly predicted mortality. A multidimensional index, the PILE score, was constructed from PPFEV(1), interleukin-6, and knee extensor strength. Each one-point increase in PILE score (range: 1-10) was associated with a 30% increase in mortality (95% confidence interval: 0.16-0.47) after adjusting for age, race, gender, smoking, and comorbidity, resulting in a 10.4-fold higher risk of death between the highest and lowest risk category.
CONCLUSIONS: Subjects with OAD have a wide gradient of risk for mortality that can potentially be incorporated in clinical decision making. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20159492      PMCID: PMC2827353          DOI: 10.1016/j.annepidem.2009.11.005

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  48 in total

Review 1.  Systemic effects in COPD.

Authors:  Emil F M Wouters; Eva C Creutzberg; Annemie M W J Schols
Journal:  Chest       Date:  2002-05       Impact factor: 9.410

2.  Attenuation of skeletal muscle and strength in the elderly: The Health ABC Study.

Authors:  B H Goodpaster; C L Carlson; M Visser; D E Kelley; A Scherzinger; T B Harris; E Stamm; A B Newman
Journal:  J Appl Physiol (1985)       Date:  2001-06

Review 3.  The bootstrap: a technique for data-driven statistics. Using computer-intensive analyses to explore experimental data.

Authors:  A Ralph Henderson
Journal:  Clin Chim Acta       Date:  2005-09       Impact factor: 3.786

4.  Spirometric reference values from a sample of the general U.S. population.

Authors:  J L Hankinson; J R Odencrantz; K B Fedan
Journal:  Am J Respir Crit Care Med       Date:  1999-01       Impact factor: 21.405

5.  Airflow limitation is underrecognized in well-functioning older people.

Authors:  G W Waterer; J Y Wan; S B Kritchevsky; R G Wunderink; S Satterfield; D C Bauer; A B Newman; D R Taaffe; R L Jensen; R O Crapo
Journal:  J Am Geriatr Soc       Date:  2001-08       Impact factor: 5.562

6.  Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly.

Authors:  T B Harris; L Ferrucci; R P Tracy; M C Corti; S Wacholder; W H Ettinger; H Heimovitz; H J Cohen; R Wallace
Journal:  Am J Med       Date:  1999-05       Impact factor: 4.965

7.  Lung function, respiratory symptoms, and mortality: results from the Busselton Health Study.

Authors:  M W Knuiman; A L James; M L Divitini; G Ryan; H C Bartholomew; A W Musk
Journal:  Ann Epidemiol       Date:  1999-07       Impact factor: 3.797

8.  Raised CRP levels mark metabolic and functional impairment in advanced COPD.

Authors:  R Broekhuizen; E F M Wouters; E C Creutzberg; A M W J Schols
Journal:  Thorax       Date:  2005-07-29       Impact factor: 9.139

9.  Inflammatory response and body composition in chronic obstructive pulmonary disease.

Authors:  A A Eid; A A Ionescu; L S Nixon; V Lewis-Jenkins; S B Matthews; T L Griffiths; D J Shale
Journal:  Am J Respir Crit Care Med       Date:  2001-10-15       Impact factor: 21.405

10.  Measuring fitness in healthy older adults: the Health ABC Long Distance Corridor Walk.

Authors:  E M Simonsick; P S Montgomery; A B Newman; D C Bauer; T Harris
Journal:  J Am Geriatr Soc       Date:  2001-11       Impact factor: 5.562

View more
  14 in total

1.  Is age-related decline in lean mass and physical function accelerated by obstructive lung disease or smoking?

Authors:  Bram van den Borst; Annemarie Koster; Binbing Yu; Harry R Gosker; Bernd Meibohm; Douglas C Bauer; Stephen B Kritchevsky; Yongmei Liu; Anne B Newman; Tamara B Harris; Annemie M W J Schols
Journal:  Thorax       Date:  2011-07-01       Impact factor: 9.139

2.  A Multidimensional Risk Score to Predict All-Cause Hospitalization in Community-Dwelling Older Individuals With Obstructive Lung Disease.

Authors:  Rosanne J H C G Beijers; Bram van den Borst; Anne B Newman; Sachin Yende; Stephen B Kritchevsky; Patricia A Cassano; Douglas C Bauer; Tamara B Harris; Annemie M W J Schols
Journal:  J Am Med Dir Assoc       Date:  2016-02-23       Impact factor: 4.669

3.  The influence of abdominal visceral fat on inflammatory pathways and mortality risk in obstructive lung disease.

Authors:  Bram van den Borst; Harry R Gosker; Annemarie Koster; Binbing Yu; Stephen B Kritchevsky; Yongmei Liu; Bernd Meibohm; Thomas B Rice; Michael Shlipak; Sachin Yende; Tamara B Harris; Annemie M W J Schols
Journal:  Am J Clin Nutr       Date:  2012-07-18       Impact factor: 7.045

Review 4.  The expanding role of biomarkers in the assessment of smoking-related parenchymal lung diseases.

Authors:  Tracy J Doyle; Victor Pinto-Plata; Danielle Morse; Bartolome R Celli; Ivan O Rosas
Journal:  Chest       Date:  2012-10       Impact factor: 9.410

Review 5.  Multidimensional prognostic indices for use in COPD patient care. A systematic review.

Authors:  Wouter D van Dijk; Lisette van den Bemt; Saskia van den Haak-Rongen; Erik Bischoff; Chris van Weel; Johannes C C M in 't Veen; Tjard R J Schermer
Journal:  Respir Res       Date:  2011-11-14

Review 6.  Role of IL-6 in asthma and other inflammatory pulmonary diseases.

Authors:  Mercedes Rincon; Charles G Irvin
Journal:  Int J Biol Sci       Date:  2012-10-25       Impact factor: 6.580

7.  Three-year follow-up of Interleukin 6 and C-reactive protein in chronic obstructive pulmonary disease.

Authors:  Renata Ferrari; Suzana E Tanni; Laura M O Caram; Corina Corrêa; Camila R Corrêa; Irma Godoy
Journal:  Respir Res       Date:  2013-02-20

8.  Prediction of COPD-specific health-related quality of life in primary care COPD patients: a prospective cohort study.

Authors:  Lara Siebeling; Jammbe Z Musoro; Ronald B Geskus; Marco Zoller; Patrick Muggensturm; Anja Frei; Milo A Puhan; Gerben ter Riet
Journal:  NPJ Prim Care Respir Med       Date:  2014-08-28       Impact factor: 2.871

9.  Role of Serum Interleukin 6, Albumin and C-Reactive Protein in COPD Patients.

Authors:  Mohammad Emami Ardestani; Omid Zaerin
Journal:  Tanaffos       Date:  2015

10.  What is the impact of different spirometric criteria on the prevalence of spirometrically defined COPD and its comorbidities? Results from the population-based KORA study.

Authors:  Stefan Karrasch; Irene Brüske; Maia P Smith; Barbara Thorand; Cornelia Huth; Karl-Heinz Ladwig; Florian Kronenberg; Joachim Heinrich; Rolf Holle; Annette Peters; Holger Schulz
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.